Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

NCT02194738 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT02194738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02194738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Lead sponsor
National Cancer Institute (NCI)
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 26, 2014
Completion date
September 21, 2027
Enrollment
7,458 (actual)
Sites
1,660

Conditions

As the registry lists them; a condition with its own page is linked.

stage ib lung non-small cell carcinoma ajcc v7, stage ii lung non-small cell cancer ajcc v7, stage iia lung cancer ajcc v8, stage iib lung cancer ajcc v8, stage iiia lung cancer ajcc v8, stage iiia lung non-small cell cancer ajcc v7, stage iiib lung cancer ajcc v8